Advertisement
Research
Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a...
Cost Effectiveness and Resource Allocation 2016 14:4
Published on: 17 February 2016
Research
The Palestinian government has been under increasing pressure to improve provision of health services while seeking to effectively employ its scare resources. Governmental hospitals remain the leading costly u...
Cost Effectiveness and Resource Allocation 2016 14:3
Published on: 3 February 2016
Review
Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater empha...
Cost Effectiveness and Resource Allocation 2016 14:2
Published on: 26 January 2016
Research
Cambodia has been reconstructing its economy and health sector since the end of conflict in the 1990s. There have been gains in life expectancy and increased health expenditure, but Cambodia still lags behind ...
Cost Effectiveness and Resource Allocation 2016 14:1
Published on: 22 January 2016
Research
Despite improvements in a number of health outcome indicators partly due to the National Health Insurance Scheme (NHIS), Ghana is unlikely to attain all its health-related millennium development goals before t...
Cost Effectiveness and Resource Allocation 2015 13:23
Published on: 26 December 2015
Research
The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific economic model based on a chronic obstructive pulmona...
Cost Effectiveness and Resource Allocation 2015 13:22
Published on: 12 December 2015
Research
All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimburs...
Cost Effectiveness and Resource Allocation 2015 13:21
Published on: 10 December 2015
Research
The rapid and continuous growth of health care cost aggravates the frequently low priority and less attention given in financing laboratory services. The poorest countries have the highest out-of-pocket spend...
Cost Effectiveness and Resource Allocation 2015 13:20
Published on: 8 December 2015
Research
In the Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST elevation myocardial infarction (FAMOUS) clinical trial, FFR was shown to significantly reduce coro...
Cost Effectiveness and Resource Allocation 2015 13:19
Published on: 14 November 2015
Research
Sequential treatment of ankylosing spondylitis (AS) that includes tumour necrosis factor-α antagonists (anti-TNF agents) has been applied in most of the Western countries. Existing cost-effectiveness (CE) mode...
Cost Effectiveness and Resource Allocation 2015 13:18
Published on: 7 October 2015
Research
In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of ...
Cost Effectiveness and Resource Allocation 2015 13:17
Published on: 6 October 2015
Research
Prepaid contributory systems are increasingly being recognized as key mechanisms in achieving universal health coverage in low and middle-income countries. Peru created the Seguro Integral de Salud (SIS) to in...
Cost Effectiveness and Resource Allocation 2015 13:16
Published on: 19 September 2015
Research
After implementation of the PREDICA annual chest X-ray (CXR) screening program in smokers in the general practice setting of Varese-Italy a significant reduction in lung cancer-specific mortality (18 %) was ob...
Cost Effectiveness and Resource Allocation 2015 13:15
Published on: 12 September 2015
Research
This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for measles in Be...
Cost Effectiveness and Resource Allocation 2015 13:14
Published on: 20 August 2015
Research
Tiotropium (TIO) is a well-established bronchodilator, LAMA (long-acting anticholinergic), for the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). Clinical evidence suggests ...
Cost Effectiveness and Resource Allocation 2015 13:13
Published on: 19 August 2015
Research
For end-users of diabetes models that include UKPDS 82 risk equations, an important question is how well these new equations perform. Consequently, the principal objective of this study was to validate the UKP...
Cost Effectiveness and Resource Allocation 2015 13:12
Published on: 4 August 2015
Research
The aim of this study was to compare the cost-utility of the first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with e...
Cost Effectiveness and Resource Allocation 2015 13:10
Published on: 9 June 2015
Research
Certolizumab pegol, a PEGylated tumour necrosis factor (TNF)-inhibitor, improves the clinical signs and symptoms of rheumatoid arthritis (RA) when used in combination with methotrexate or as monotherapy. This ...
Cost Effectiveness and Resource Allocation 2015 13:11
Published on: 9 June 2015
Research
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder which can affect multiple organs of the body, requiring ongoing disease management and healthcare resource utilization. The economic impact o...
Cost Effectiveness and Resource Allocation 2015 13:9
Published on: 6 May 2015
Commentary
The exponential increase of knowledge in the life sciences field, more specifically in health sciences, in the past few years has brought additional levels of complexity when deciding and implementing strategi...
Cost Effectiveness and Resource Allocation 2015 13:8
Published on: 1 May 2015
Research
Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the ma...
Cost Effectiveness and Resource Allocation 2015 13:7
Published on: 28 April 2015
Research
Pneumococcal diseases in children under five years are common and preventable. In Colombia there are two pneumococcal conjugate vaccines (PCV) that have proved clinical efficacy. The aim was to estimate the co...
Cost Effectiveness and Resource Allocation 2015 13:6
Published on: 10 April 2015
Research
In 2004, the largest HIV prevention project (Avahan) conducted globally was implemented in India. Avahan was implemented by NGOs supported by state lead partners in order to provide HIV prevention services to ...
Cost Effectiveness and Resource Allocation 2015 13:5
Published on: 29 March 2015
Research
The purpose of this study was to assess the consequences of a national immunization program with HPV vaccine for both boys and girls in Denmark, including the prophylactic effects on all potentially vaccine pr...
Cost Effectiveness and Resource Allocation 2015 13:4
Published on: 11 February 2015
Research
This paper examines the cost-effectiveness of achieving increases in the use of oral rehydration solution and zinc supplementation in the management of acute diarrhea in children under 5 years through social f...
Cost Effectiveness and Resource Allocation 2015 13:3
Published on: 5 February 2015
